Abiopharma

22ND CENTURY GROUP, INC. (XXII)

Symbol	XXII
Name	22ND CENTURY GROUP, INC.
Sector	HEALTH CARE
Region	North America
Industry	Cigarettes
Address	8560 MAIN STREET, WILLIAMSVILLE, IN 14221
Telephone	(716) 270-1523
Fax	—
Email	—
Website	https://www.xxiicentury.com
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0001347858
Description	22nd Century Group Inc is a US-based plant biotechnology company. It focuses on developing technology that allows the increase or decrease in the level of nicotine and other nicotinic alkaloids in tobacco plants and levels of cannabinoids in cannabis plants through genetic engineering and plant breeding. The company is engaged in the research and development of potentially less harmful or modified risk tobacco products and novel tobacco plant varieties. Other business activities of the company include manufacture, marketing, sales, and distribution of SPECTRUM and VLN proprietary cigarettes, contract manufacturing of third-party branded tobacco products, research and development of plant varieties of hemp/cannabis, the sale of branded proprietary tobaccos, and among others. Additional info from NASDAQ: 22nd Century Group Inc is a US-based plant biotechnology company. It focuses on developing technology that allows the increase or decrease in the level of nicotine and other nicotinic alkaloids in tobacco plants and levels of cannabinoids in cannabis plants through genetic engineering and plant breeding. The company is engaged in the research and development of potentially less harmful or modified risk tobacco products and novel tobacco plant varieties. Other business activities of the company include manufacture, marketing, sales, and distribution of SPECTRUM and VLN proprietary cigarettes, contract manufacturing of third-party branded tobacco products, research and development of plant varieties of hemp/cannabis, the sale of branded proprietary tobaccos, and among others.

2026-08-14 17:34

New Form S-8 - 22nd Century Group, Inc. Filed: 2026-08-14 AccNo: 0001493152-26-038431 Size: 240 KB

2026-08-14 17:19

New Form 424B3 - 22nd Century Group, Inc. Filed: 2026-08-14 AccNo: 0001493152-26-038365 Size: 16 KB

2026-08-14 16:45

New Form SCHEDULE 13G/A - 22nd Century Group, Inc. Filed: 2026-08-14 AccNo: 0001193125-26-352074 Size: 16 KB

2026-08-13 10:06

(30% Negative) 22ND CENTURY GROUP, INC. (XXII) Reports Q3 2026 Financial Results

2026-08-13 10:00

22nd Century Group Reports Second Quarter 2026 Financial Results

2026-07-16 13:00

22nd Century Group (Nasdaq: XXII) Appoints Katherine Rouse-Bailey as Vice President of Marketing

2026-07-02 21:15

(99% Neutral) 22ND CENTURY GROUP, INC. (XXII) Announces Business Combination

2026-06-25 07:03

New Form EFFECT - 22nd Century Group, Inc. Filed: 2026-06-24 AccNo: 9999999995-26-002112 Size: 1 KB

2026-06-23 18:23

New Form DEF 14A - 22nd Century Group, Inc. Filed: 2026-06-23 AccNo: 0001493152-26-029807 Size: 1 MB

2026-06-12 18:15

New Form PRE 14A - 22nd Century Group, Inc. Filed: 2026-06-12 AccNo: 0001493152-26-028521 Size: 1 MB

No clinical trials found for this company.

No clinical products found for this company.